Estradiol

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

28 Suppliers, 11 USDMF, 8 CEP/COS, 2 JDMF, 2 EU WC, 10 KDMF, 32 NDC API, 16 Listed Suppliers

DEVELOPMENTS

38 Drug(s) in Development

38 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

470 Dossiers, 197 FDA Orange Book, 190 Europe, 30 Canada, 18 Australia, 25 South Africa, 10 Listed Dossiers

DRUG PRODUCT COMPOSITION

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.025MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.0375MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.06MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.075MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/24HR, INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR, SYSTEM;TRANSDERMAL - 0.025MG/24HR, SYSTEM;TRANSDERMAL - 0.0375MG/24HR, SYSTEM;TRANSDERMAL - 0.05MG/24HR, SYSTEM;TRANSDERMAL - 0.075MG/24HR, SYSTEM;TRANSDERMAL - 0.1MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR, TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG;0.5MG, TABLET;VAGINAL - 10MCG, TABLET;VAGINAL - 25MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 0.5MG;100MG, CAPSULE;ORAL - 1MG;100MG, GEL, METERED;TRANSDERMAL - 0.06% (1.25GM/ACTIVATION), FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR, TABLET;ORAL - 0.25MG;0.5MG, TABLET;ORAL - 0.5MG;1MG, GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION), SPRAY;TRANSDERMAL - 1.53MG/SPRAY, GEL;TRANSDERMAL - 0.1%, CREAM;VAGINAL - 0.01%

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 33 BASF, 20 Roquette, 16 Microlex e.U, 16 Seppic, 14 Corel Pharma Chem, 13 Gangwal Chemicals, 12 Sigachi Industries, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 Nanjing Well Pharmaceutical, 9 Gangwal Healthcare, 8 Actylis, 8 SPI Pharma, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 4 Ingredion Pharma Solutions, 4 Boai NKY Pharmaceuticals Ltd, 4 Kima Chemical, 4 Vasa Pharmachem, 4 Prachin Chemical, 4 DKSH, 4 ACG Worldwide, 3 The Dow Chemical Company, 3 Pharmatrans-Sanaq, 2 Qualicaps, 2 Ulanqab Kema New Material, 2 Lubrizol Life Science Health, 2 Nanjing Bold Chemical, 2 Seqens, 2 Nomisma Healthcare, 2 Finar, 2 Nippon Fine Chemical, 2 Aeon Procare, 2 Jai Radhe Sales, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 BioSpectra, 1 Clariant, 1 Rochem International Inc, 1 Pfanstiehl, 1 Doshion Polyscience, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

81 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 41 Direct Compression, 35 Controlled & Modified Release, 34 Disintegrants & Superdisintegrants, 32 Solubilizers, 30 Granulation, 27 Topical, 26 Thickeners and Stabilizers, 22 Film Formers & Plasticizers, 21 Parenteral, 21 Lubricants & Glidants, 18 Taste Masking, 16 Co-Processed Excipients, 13 Emulsifying Agents, 9 Empty Capsules, 9 API Stability Enhancers, 8 Chewable & Orodispersible Aids, 6 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 94 Finished Drug Prices

MARKET PLACE

10 APIs, 3 DOSSIERS // FDF

PATENTS

130 US Patents, 5 US Exclusivities

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 4 EDQM Standards, 3 USP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

37 News

37 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Estradiol

Estradiol

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

28 Suppliers

11 USDMF

8 CEP/COS

2 JDMF

2 EU WC

10 KDMF

32 NDC API

16 Listed Suppliers

DEVELOPMENTS

38 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

470 Dossiers

197 FDA Orange Book

190 Europe

30 Canada

18 Australia

25 South Africa

10 Listed Dossiers

DRUG PRODUCT COMPOSITION

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.025MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.0375MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.06MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.075MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/24HR

INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR

SYSTEM;TRANSDERMAL - 0.025MG/24HR

SYSTEM;TRANSDERMAL - 0.0375MG/24HR

SYSTEM;TRANSDERMAL - 0.05MG/24HR

SYSTEM;TRANSDERMAL - 0.075MG/24HR

SYSTEM;TRANSDERMAL - 0.1MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR

TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1MG;0.5MG

TABLET;VAGINAL - 10MCG

TABLET;VAGINAL - 25MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 0.5MG;100MG

CAPSULE;ORAL - 1MG;100MG

GEL, METERED;TRANSDERMAL - 0.06% (1.25GM/ACTIVATION)

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR

TABLET;ORAL - 0.25MG;0.5MG

TABLET;ORAL - 0.5MG;1MG

GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION)

SPRAY;TRANSDERMAL - 1.53MG/SPRAY

GEL;TRANSDERMAL - 0.1%

CREAM;VAGINAL - 0.01%

RELATED EXCIPIENT COMPANIES

Suppliers

39 Kerry

33 BASF

20 Roquette

16 Microlex e.U

16 Seppic

14 Corel Pharma Chem

13 Gangwal Chemicals

12 Sigachi Industries

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 Nanjing Well Pharmaceutical

9 Gangwal Healthcare

8 Actylis

8 SPI Pharma

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 DFE Pharma

7 Ideal Cures Pvt Ltd

6 Lonza Capsugel

4 Ingredion Pharma Solutions

TABLET;ORAL - 0.5MG;0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;VAGINAL - 25MCG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons